Screen LibraryThymosins in health and disease：2nd international symposium
Saved in:
| Corporate Authors: | ; |
|---|---|
| Group Author: | ; ; |
| Published: |
Blackwell Pub. on behalf of the New York Academy of Sciences,
|
| Publisher Address: | Boston, Mass. |
| Publication Dates: | 2010. |
| Literature type: | Book |
| Language: | English |
| Series: |
Annals of the New York Academy of Sciences, ; v. 1194 |
| Subjects: | |
| Carrier Form: | xi, 230 p.: ill. ; 23 cm. |
| Publication Frequency: | Also issued online |
| ISBN: |
9781573318013 1573318019 |
| Index Number: | R335 |
| CLC: |
R335-532 Q574-532 |
| Call Number: | Q574-532/T549/2009 |
| Contents: |
"This volume presents manuscripts stemming from the "Second International Symposium on Thymosins in Health and Disease," held on September 30 to October 2, 2009 in Catania, Italy."--P. v. Includes bibliographical references. Structure, design, immunology, and molecular biology of thymosin alpha 1 and thymosin beta 4. Thymosin [alpha]1 : the regulator of regulators? / by Bonifazi Pierluigi ... [et al.] -- Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 / by Claudia Matteucci ... [et al.] -- Prothymosin [alpha] as robustness molecule against ischemic stress to brain and retina / by Hiroshi Ueda ... [et al.] "This meeting brought together many of the leading scientists and clinicians working in the field to report on the latest advances in the chemistry, biology and clinical applications of the thymosins. The use of chemically defined and synthesized molecules, rather than crude or partially purified extracts has enabled scientists working in this field to acquire definitive information on the molecular biology, immunology and potential clinical applications of this important class of BRMs. This volume is a synthesis of the four plenary sessions: on the advances being made in the structure, design, immunology and molecular biology of thymosin alpha 1, prothymosin alpha and thymosin beta4; the role of the thymosins in cardioprotection, neuroplasticity, stem cells, wound healing, inflammation and angiogenesis; clinical applications of T[alpha]1 and other BRMs; and the current status of translational trials with T[beta]4 in areas of wound repair, cardiovascular disease, epidermolysis bullosa and eye injuries."--Society website. |